Markers of inflammation predict the long-term risk of developing chronic kidney disease: a population-based cohort study.
about
Risk Factors for Development and Progression of Chronic Kidney Disease: A Systematic Review and Exploratory Meta-AnalysisToll-like receptor activation: from renal inflammation to fibrosisInflammation and coagulation markers and kidney function decline: the Multi-Ethnic Study of Atherosclerosis (MESA)Positioning of Tacrolimus for the Treatment of Diabetic Nephropathy Based on Computational Network AnalysisAcoustic radiation force impulse imaging for noninvasive evaluation of renal parenchyma elasticity: preliminary findingsWhite blood cell count predicts the odds of kidney function decline in a Chinese community-based population.Erectile dysfunction and risk of end stage renal disease requiring dialysis: a nationwide population-based study.Circulating TNF receptors are significant prognostic biomarkers for idiopathic membranous nephropathyInflammation and renal function after a four-year follow-up in subjects with unimpaired glomerular filtration rate: results from the observational, population-based CARLA cohortEffect of renal impairment on cognitive function during a 3-year follow up in elderly patients with type 2 diabetes: Association with microinflammation.Long-term systemic inflammation and cognitive impairment in a population-based cohort.Association of hsCRP, white blood cell count and ferritin with renal outcome in chronic kidney disease patients.Associations of epicardial fat with coronary calcification, insulin resistance, inflammation, and fibroblast growth factor-23 in stage 3-5 chronic kidney disease.Prevalence and risk factors of CKD in Chinese patients with periodontal diseaseResults from the Atherosclerosis Risk in Communities study suggest that low serum magnesium is associated with incident kidney diseaseAssociation of C-reactive protein, tumor necrosis factor-alpha, and interleukin-6 with chronic kidney diseaseNonapnea Sleep Disorders in Patients Younger than 65 Years Are Significantly Associated with CKD: A Nationwide Population-Based Study.Relationship between Plasma Leptin Level and Chronic Kidney Disease.Kidney Dysfunction and Markers of Inflammation in the Multicenter AIDS Cohort Study.Inflammation as a Risk of Developing Chronic Kidney Disease in Rheumatoid Arthritis.Alteration of histone H3K4 methylation in glomerular podocytes associated with proteinuria in patients with membranous nephropathy.Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC.Age sensitizes the kidney to heme protein-induced acute kidney injury.Inflammatory and injury signals released from the post-stenotic human kidneyComparison of serum cystatin C, serum creatinine, measured GFR, and estimated GFR to assess the risk of kidney failure in American Indians with diabetic nephropathyLong-term variability of inflammatory markers and associated factors in a population-based cohort.Remnant nephron physiology and the progression of chronic kidney disease.Inflammation regulates fibroblast growth factor 23 production.Serum Albumin and High-Sensitivity C-reactive Protein are Independent Risk Factors of Chronic Kidney Disease in Middle-Aged Japanese Individuals: the Circulatory Risk in Communities Study.Ambulatory Blood Pressure in Chronic Kidney Disease: Ready for Prime Time?Cardiovascular risk markers associated with arterial calcification in patients with chronic kidney disease Stages 3 and 4.Recent findings on the effects of marine-derived n-3 polyunsaturated fatty acids on urinary albumin excretion and renal function.Effects of hemodiafiltration on uremic inflammation.Novel biomarkers for the progression of diabetic nephropathy: soluble TNF receptors.Adipokines promote chronic kidney disease.C-reactive protein and hypertension.The Western Diet and Chronic Kidney Disease.A kidney-selective biopolymer for targeted drug delivery.C-Reactive Protein and Risk of ESRD: Results From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).OLDER PEOPLE WITH CHRONIC KIDNEY DISEASE: DEFINITION, AND INFLUENCE OF BIOMARKERS AND MEDICATIONS UPON CARDIOVASCULAR AND RENAL OUTCOMES.
P2860
Q26764823-24C6B649-3E26-406A-9674-1B61395F7EE6Q26796639-6EAB46C8-452B-4FD5-9A82-6B3AFB1634C3Q28387350-18801234-FFE1-42DE-ACC2-723445FDF64FQ28468441-4A2B61DC-8D54-48D6-969B-85439F3CB01EQ30452095-0B50B28D-3853-4B7E-9E21-D728DB9052C6Q33776383-A51E62C1-F362-49E5-917A-92035A7B7A9CQ33889861-DDD692EE-AC3C-45E5-984E-A58D487E730BQ34011274-0F003BB8-3754-46F4-8CBF-9F323DEFEC1BQ34258668-2103713D-CABD-4820-8DDD-E300916A1F19Q34299678-DB83E305-8570-49C0-8CC7-5C953F578726Q34336957-01FDC675-F09D-44AE-9DE4-6845B149A0D4Q34541172-156C7E47-0A9C-4EBE-B588-93B2BEA69AC6Q34563990-562AC893-19F1-4A9E-B9B2-AF9FBAAED988Q34947585-93FDC91B-085D-4F3F-8F93-623E4D66F54DQ35243414-91459C7D-A621-45D7-8779-C5F9DCE84AE9Q35646625-3ACDBC6E-44F2-4A85-921D-1F4D65E68277Q35806577-59B80ACB-A5ED-4ED2-86CE-AFC6575925D8Q35990851-3CED74F4-03F1-40D0-B7AB-1251264093CBQ36024460-F56434CF-8849-4B7D-B791-1133D1B8FBC6Q36106803-358062C4-BBA1-41F8-B3F1-59982681755DQ36195369-685F6CFC-6474-48A5-B4B3-ACF747CE787EQ36443224-AD1970BC-9552-4E7E-A913-A27B8380D52DQ36593159-86CADE35-E999-4F72-8AF1-615501E9DB06Q36609944-6FDF0397-4A9B-4508-A056-7CDB7EBA85C7Q36876230-39AD53B5-E9B4-4EC4-8BBA-72A132EBD00FQ37096276-453DCDA0-9B65-4528-AAA6-633DA58231E9Q37228467-941D088A-941E-497B-B276-AEBAC0AF8CB9Q37243107-1B5666F1-174B-4DD0-8BE4-1DC0ABE80384Q37387222-6FBA12CD-392B-4B2F-A78A-B59381406550Q37616714-5B5E6D21-DD8F-487D-AFA6-CA1196DE6AA7Q37670438-67512FF1-3E56-41BC-8C30-8294E8B5C0BBQ38034098-1F95F50E-ADE9-44E3-BEE4-CEA957818AA1Q38087135-A5488764-E5CB-43F8-BFF1-E09738080D56Q38105277-0ABE6A1F-F48D-4618-A48D-FFEC4196D7F1Q38157808-CE57414D-FA99-4569-889B-52D53840FAB2Q38162367-C76E0E75-FFCA-4A6E-813C-D49E3C112605Q38371171-E8037882-600A-42E3-81B5-42C13AD4D4E4Q38804663-2139DADD-9D49-432C-8139-6FDA9A563A99Q38819669-2EDA6B66-9451-47EF-915C-E275F179B309Q38882637-257FD33E-E966-4716-A475-75BA61511AE3
P2860
Markers of inflammation predict the long-term risk of developing chronic kidney disease: a population-based cohort study.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Markers of inflammation predic ...... population-based cohort study.
@ast
Markers of inflammation predic ...... population-based cohort study.
@en
type
label
Markers of inflammation predic ...... population-based cohort study.
@ast
Markers of inflammation predic ...... population-based cohort study.
@en
prefLabel
Markers of inflammation predic ...... population-based cohort study.
@ast
Markers of inflammation predic ...... population-based cohort study.
@en
P2093
P2860
P50
P356
P1433
P1476
Markers of inflammation predic ...... population-based cohort study.
@en
P2093
Anoop Shankar
Barbara E K Klein
Carla R Schubert
F Javier Nieto
Karen J Cruickshanks
Kristine E Lee
Liping Sun
Paul Muntner
Peter C Brazy
P2860
P2888
P304
P356
10.1038/KI.2011.283
P407
P577
2011-08-24T00:00:00Z